Achievement of Cure with Gefitinib in Advanced Lung Adenocarcinoma Harboring an Activating EGFR Mutation: A Case Report

Tyrosine kinase inhibitors (TKIs) of the epidermal growth factor receptor (EGFR) may achieve long-term survival in selected cases with advanced non-small cell lung cancer harboring activating mutations in the EGFR gene, but a cured case has not been reported yet. Here, we present the first case of E...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwata, Taiji, Yoneda, Kazue, Kobayashi, Kenichi, Oyama, Rintarou, Matumiya, Hiroki, Shinohara, Shuichi, Takenaka, Masaru, Oka, Soichi, Chikaishi, Yasuhiro, Imanishi, Naoko, Kuroda, Koji, Tanaka, Fumihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075735/
https://www.ncbi.nlm.nih.gov/pubmed/27790122
http://dx.doi.org/10.1159/000449371

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075735/
https://www.ncbi.nlm.nih.gov/pubmed/27790122
http://dx.doi.org/10.1159/000449371

Ejemplares similares